Radiological review of incidence breast cancers

• Published in: Journal of medical screening 2000-01, Vol.7 (4), p.177-183
• Main Authors: Moberg, K, Grundström, H, Lundquist, H, Svane, G, Havervall, E, Muren, C
• Format: Article
• Language: English
• Subjects: Breast Neoplasms - diagnostic imaging; Female; Humans; Mammography - standards; Mass Screening - standards; Medicin och hälsovetenskap; Observer Variation; Retrospective Studies; Sensitivity and Specificity
• ISSN: 0969-1413; 1475-5793
• DOI: 10.1136/jms.7.4.177

Objectives To examine the rate of incidence cancers detectable on review of previous screening mammograms using two reviewing methods. To compare the results with a previous study of interval cancers using the same reviewing methods. Setting Almost 50 000 women are regularly invited for service screening at Stockholm Söder Hospital. From 1989 to 1993, 119 women were identified with breast cancer detected at screening and the previous round attendance (incidence cancer). Methods Screening mammograms, obtained before detection of the incidence cancers, were reviewed first mixed with other screening images (ratio 1:8) and then non-mixed. Reviewers from the screening unit responsible for the mammograms as well as reviewers from other units interpreted all images by both single and double reading. Results The proportion detected on retrospective review varied between 5% and 50% depending on the review method used and the number of reviewers included to classify a case as truly identified. Generally more cancers were detected when non-mixed samples of mammograms were reviewed than when mixed samples were reviewed (mean increase 23%) and when interpreted by double reading compared with single reading (mean increase 14%). Conclusions In an experimental retrospective set up, fewer incidence cancers were identified in mixed than in non-mixed review. Generally more incidence cancers were identified on review (22%) than previously reported for interval cancers (14%), probably reflecting differences in tumour biology and growth. How many women with potentially visible incidence cancers would have benefited from earlier tumour detection still needs to be evaluated.